Your browser doesn't support javascript.
loading
Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Haanen, J B A G; Carbonnel, F; Robert, C; Kerr, K M; Peters, S; Larkin, J; Jordan, K.
Afiliação
  • Haanen JBAG; Netherlands Cancer Institute, Division of Medical Oncology, Amsterdam, The Netherlands.
  • Carbonnel F; Department of Gastroenterology, Kremlin Bicêtre Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.
  • Robert C; Department of Medicine, Dermatology Unit, Gustave Roussy Cancer Campus, Villejuif, France.
  • Kerr KM; Department of Pathology, Aberdeen University Medical School & Aberdeen Royal Infirmary, Aberdeen, UK.
  • Peters S; Oncology Department, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland.
  • Larkin J; Royal Marsden Hospital NHS Foundation Trust, London, UK.
  • Jordan K; Department of Medicine V, Hematology, Oncology and Rheumatology, University Hospital of Heidelberg, Heidelberg, Germany.
Ann Oncol ; 28(suppl_4): iv119-iv142, 2017 Jul 01.
Article em En | MEDLINE | ID: mdl-28881921

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos / Antineoplásicos Imunológicos / Oncologia / Anticorpos Monoclonais Tipo de estudo: Diagnostic_studies / Etiology_studies / Guideline / Observational_studies / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos / Antineoplásicos Imunológicos / Oncologia / Anticorpos Monoclonais Tipo de estudo: Diagnostic_studies / Etiology_studies / Guideline / Observational_studies / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article